期刊文献+

超声内镜造影增强技术在消化系统疾病诊治中的应用 被引量:1

Application of the contrast-enhanced endoscopic ultrasonography in diagnosis and treatment of digestive diseases
下载PDF
导出
摘要 随着超声内镜技术的发展,超声内镜检查技术也有了很大的发展:彩色多普勒成像,造影增强成像,三维成像,组织谐波成像以及弹性成像等,最重要的发展之一即超声内镜造影增强技术(contrast-enhanced endoscopic ultrasonography,CE-EUS)是使用包裹在抗氧化外壳的含气微泡作为超声造影剂,通过静脉快速注射,微气泡作用使多普勒血流信号明显增强,靶病灶内的微血管系统可以通过对比增强无创观察,清晰显示肿瘤病灶内部血流的异常灌注区,有助于病变良恶性的鉴别,能大大提高肿瘤诊断及其分期的准确性。本文就CE-EUS在消化系统疾病诊治的应用进展做一综述。 With the development of endoscopic ultrasonography(EUS), its examination technology has undergone a great deal of progress, such as Color doppler imaging, contrast-enhanced endoscopic ultrasonography, three-dimensional imaging, tissue harmonic imaging, and elastography. One of the most important developments is the ability to acquire contrast-enhanced images(contrast-enhanced endoscopic ultrasonography, CE-EUS). Enhancement technique is the use of wrapped in antioxidant shell of gas bubble as ultrasound contrast agents quickly pushed by vein injection. Microbubbles can significantly enhance doppler blood flow signal. The microvascular system in the target lesion can clearly show the abnormal perfusion area of blood flow in the tumor lesion through contrast enhancement of non-invasive observation, which is conducive to the differentiation of benign and malignant lesions and can greatly improve the accuracy of tumor diagnosis and staging. This paper is to review the advances of CE-EUS in diagnosis and treatment of digestive system diseases.
作者 尔丽绵 冯志杰 Er Limian;Feng Zhijie(Department of Endoscopy,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Gastroenterology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处 《临床荟萃》 CAS 2019年第9期790-794,共5页 Clinical Focus
关键词 腔内超声检查 消化系统疾病 endosonography diseases of digestive system
  • 相关文献

参考文献4

二级参考文献87

  • 1David Carrier,沈蕾.艺术博物馆的诗学[J].文化艺术研究,2010,3(3):233-238. 被引量:4
  • 2刘晓岚,张学颖,郝明,王伟力,刘林林,吴镇凤,姜洪伟.人类mdm2基因多态性与非小细胞肺癌临床症状及病理类型的关联性[J].吉林大学学报(医学版),2006,32(3):465-469. 被引量:5
  • 3Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocareinoma of the esophagus and gastric cardia [J]. JAMA,1991,265(22) :2960.
  • 4Ohmiya N, Taguchi A, Mabuchi N, et al. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis[J]. J Clin Oncol,2006,24(27) :4434-4440.
  • 5Zhou G, Zhai Y. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population [ J]. Clin Cancer Res,2007,13(9) :2627-2633.
  • 6Campbell IG,Eccles DM, Choong DY, et al. No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer[J]. Cancer Lett,2006,240(2) :195-197.
  • 7Alhopuro P, Ylisaukko-Oia SK, Koskinen WJ, et al. The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck[J]. J Med Genet,2005,42(9): 694- 698.
  • 8Sirigu F, Capeccioni S, Dessi A, et al. Helicobacter pylori in Barrett's esophagus and in normal or inflamed esophageal mucosa:a retrospective study[J]. Riv Eur Sci Med Farmaeol, 1994,16(5/6) :131-134.
  • 9Kodama M, Fujioka T, Murakami K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric[J]. Gastroenterol Hepatol, 2005, 20(6):941- 946.
  • 10[1]Levy MJ,Wiersema MJ.Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer.Oncology (Williston Park) 2002; 16:29-38,43; discussion 44,47-49,53-56

共引文献62

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部